Results 61 to 70 of about 5,456,142 (288)
Food Chemistry International, EarlyView.The study demonstrates how functional foods, medicinal plants, phytochemicals, bioactive compounds and essential nutrients combat metabolic diseases. It highlights their mechanisms, including antioxidant, anti‐inflammatory, insulin‐sensitising, lipid‐regulating, gut microbiota‐modulating and mitochondrial‐enhancing effects, leading to improved ...
Chinaza Godswill Awuchi +2 more
wiley +1 more source
The myth of the stigma of fatty liver: What does the evidence show?
Annals of HepatologyRecent efforts to reclassify non-alcoholic fatty liver disease (NAFLD) as metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) are intended to divert attention to the metabolic ...
Mariana M. Ramírez-Mejía +3 more
doaj +1 more source
Exploring synergistic therapy for metabolic dysfunction-associated steatotic liver disease
The global epidemic of obesity has led to a surge in metabolic-associated steatotic liver disease (MASLD), which poses a significant global health burden.
Anas Zaher, Hassan Elsaygh
core +1 more source
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Annals of HepatologyThe principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language.
Mary E. Rinella +52 more
doaj +1 more source
Protocol TOP-Study (tacrolimus organ perfusion): a prospective randomized multicenter trial to reduce ischemia reperfusion injury in transplantation of marginal liver grafts with an "ex vivo" tacrolimus perfusion [PDF]
, 2013 Background: Critical organ shortage results in the utilization of extended donor criteria (EDC) liver grafts. These marginal liver grafts are prone to increased ischemia reperfusion injury (IRI) which may contribute to deteriorated graft function and ...
Jauch, Karl-Walter +24 more
core +1 more source
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease
Lipids in Health and DiseaseSteatotic liver disease poses a serious threat to human health and has emerged as one of the most significant burdens of chronic liver disease worldwide.
Tiansu Lv +5 more
doaj +1 more source
Harnessing nutrition to combat MASLD: a comprehensive guide to food-based therapeutic strategies
Food and Agricultural ImmunologyMetabolic dysfunction-associated steatotic liver disease is a growing global health issue linked to obesity, insulin resistance, and metabolic syndrome. Diet plays a key role in its progression and management.
Claudia Reytor-González +6 more
doaj +1 more source
Gene-based therapies for steatotic liver disease
Molecular TherapyAdvances in nucleic acid delivery have positioned the liver as a key target for gene therapy, with adeno-associated virus vectors showing long-term effectiveness in treating hemophilia. Steatotic liver disease (SLD), the most common liver condition globally, primarily results from metabolic dysfunction-associated and alcohol-associated liver diseases ...
Viktoriia, Iakovleva, Ype P, de Jong
openaire +2 more sources
The number of patients whose chronic metabolic liver disease leads to the development of hepatocellular carcinoma (HCC) is increasing. In patients with non-alcoholic fatty liver disease (NAFLD), HCC can arise in both cirrhotic and non-cirrhotic livers ...
Marta Stelmach-Mardas +3 more
core +1 more source
Non-metabolic causes of steatotic liver disease
, 2023 Hepatic steatosis is caused by exaggerated hepatic lipid accumulation and is a common histological and radiological finding. Non-alcoholic fatty liver disease (NAFLD), or metabolic dysfunction associated steatotic liver disease (MASLD), is highly ...
Cecilia Jönsson +11 more
core +1 more source